IMPRIMIS PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The undersigned, Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement with MDB Capital Group, LLC (hereinafter referred to as “you” (including its correlatives) or the “Underwriter”) as follows:
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR...Underwriter’s Warrant • October 26th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This UNDERWRITER’S WARRANT (this “Warrant”) of Imprimis Pharmaceuticals, Inc., a corporation, duly organized and validly existing under the laws of the State of Delaware (the “Company”), is being issued pursuant to that certain Underwriting Agreement, dated as of __________, 2012 (the “Underwriting Agreement”), between the Company and MDB Capital Group, LLC (the “Underwriter”) relating to a firm commitment public offering (the “Offering”) of ________ shares of common stock, $0.001par value per share, of the Company (the “Common Stock”) underwritten by the Underwriter.
